IWC
ASND icon

Integrated Wealth Concepts’s Ascendis Pharma A/S ASND Stock Holding History

Integrated Wealth Concepts’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
+1,423
New +$332K ﹤0.01% 1842
2025
Q4 		– Sell
-1,562
Closed -$311K – 1639
2025
Q3 		$311K Sell
1,562
-155
-9% -$28.9K ﹤0.01% 1607
2025
Q2 		$296K Buy
+1,717
New +$280K ﹤0.01% 1552

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Integrated Wealth Concepts's ASND Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 1,423 shares worth $380K. The stake represents ﹤0.01% of the portfolio and ranks #1842 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in ASND as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in ASND in Q2 2025 and has held it in 3 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Integrated Wealth Concepts held 1,423 shares of Ascendis Pharma A/S worth $380K as of Q2 2026.
  • Ascendis Pharma A/S was a new Integrated Wealth Concepts position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1842 holding.
  • Integrated Wealth Concepts first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 3 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.